Superworth

Opko Health EPS OPK

Diluted earnings per share by quarter and over the last twelve months, from 2010.

Last 12 months, to Jun 30, 2026
−$0.09
Latest quarter, Q2 FY26
−$0.01
Fiscal year 2025
−$0.30

Opko Health's earnings per share was −$0.09 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.01.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$0.30n/a
FY2024n/an/a
FY2023n/an/a
FY2022−$0.44n/a
FY2021−$0.05−200%
FY2020$0.05n/a
FY2019−$0.53n/a
FY2018−$0.27n/a
FY2017−$0.55n/a
FY2016−$0.05n/a
FY2015−$0.17n/a
FY2014−$0.40n/a
FY2013−$0.33n/a
FY2012−$0.10n/a
FY2011−$0.01n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.01n/a−$0.09
Q1 FY26−$0.07n/a−$0.27
Q4 FY25−$0.04−300%−$0.30
Q3 FY25$0.03+0%−$0.24
Q2 FY25−$0.19n/a−$0.24
Q1 FY25−$0.10n/a−$0.06
Q4 FY24$0.02n/an/a
Q3 FY24$0.03n/an/a
Q2 FY24−$0.01n/an/a
Q4 FY23−$0.09n/an/a
Q3 FY23−$0.11n/an/a
Q1 FY23−$0.02n/a−$0.38

Against its peers

Companies in Drug Manufacturers - General nearest Opko Health's size, closest first, today.

CompanyEPS, 12 monthsGrowth
OPKOpko Health−$0.09
OMEROmeros$1.52
AMPHAmphastar Pharmaceuticals$1.70−36% a year
PCRXPacira BioSciences$0.35
ANABAnaptysbio$4.57
PAHCPhibro Animal Health$2.44+107% a year
ANIPANI Pharmaceuticals$4.70
ABUSArbutus Biopharma$0.78
COLLCollegium Pharmaceutical$1.24+19% a year
HRMYHarmony Biosciences$3.09−0% a year
PBHPrestige Consumer Healthcare$3.57−16% a year
Peer median$2.07

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Opko Health

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.